Usefulness of Chromogranin A as a Marker for Detection of Relapses of Carcinoid Tumours
The DOI matches its Crossref record.
Abstract
It is well known that peptide-producing endocrine tumours cosecrete immunoreactive chromogranin A with their characteristic hormones. Into this study 187 patients with the diagnosis malignant carcinoids or other malignancies were entered. Using chromogranin A at a cut-off level of 30.3 U/ml it was possible to discriminate between patients in remission and patients suffering a relapse with a sensitivity of 91.7% and a specificity of 96.4 %, which may be of important diagnostic value. In our study that lasted over one year we could clearly show that the measurement of chromogranin A is impressively superior to 5-hydroxyindoleacetic-acid for detecting a relapse of carcinoids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The diagnosis and medical management of advanced neuroendocrine tumors.
Kaltsas, G. A., Besser, G. M., & Grossman, A. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0014 · Cited by 674
Caplin, M., Sundin, A., Nillson, O., Baum, R. P., Klose, K. J., Kelestimur, F., Plöckinger, U., Papotti, M., Salazar, R., & Pascher, A. (2012) · Neuroendocrinology · doi:10.1159/000335594 · Cited by 301
Interest of Chromogranin A for diagnosis and follow-up of endocrine tumours
Nehar, D., Lombard‐Bohas, C., Olivieri, S., Claustrat, B., Chayvialle, J., Penes, M., Sassolas, G., & Borson‐Chazot, F. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02030.x · Cited by 177
“Nevertheless, Pirker et al. (1998) previously suggested that CgA was also more powerful than 5-HIAA for the detection of relapse of carcinoid tumours.”
BackgroundKorse, C. M., Bonfrer, J. M. G., Aaronson, N. K., Hart, A. A. M., & Taal, B. G. (2009) · Neuroendocrinology · doi:10.1159/000162876 · Cited by 61
Metadata
- Authors
- Pirker, R. A., Pont, J., Pöhnl, R., Schütz, W., Griesmacher, A., & Müller, M. M.
- Venue
- cclm
- Publisher
- Walter de Gruyter GmbH
- Published
- 1998-11-01
- Volume
- 36
- Issue
- 11
- Pages
- 837-840
- ISSN
- 1434-6621 (ISSN-L)
- 1437-4331
- OpenAlex
- W2051631475
- Cited by
- 51
- References
- 0
- FWCI
- 0.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Usefulness of Chromogranin A as a Marker for Detection of Relapses of Carcinoid Tumours. https://app.cochat.ai/papers/10.1515/cclm.1998.147
- The paper
- Pirker, R. A., Pont, J., Pöhnl, R., Schütz, W., Griesmacher, A., & Müller, M. M. (1998). Usefulness of Chromogranin A as a Marker for Detection of Relapses of Carcinoid Tumours. cclm. https://doi.org/10.1515/cclm.1998.147
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.